Evidence map›Paper›PMID 35645249›Full record

ReviewDiseases (Basel, Switzerland)2022

Natural Bioactive Products and Alzheimer's Disease Pathology: Lessons from

María D Navarro-Hortal, Jose M Romero-Márquez, Safa Osta, Victoria Jiménez-Trigo, Pedro Muñoz-Ollero, Alfonso Varela-López

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Diseases (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. International journal of molecular sciences · 2026
    Review
  2. Frontiers in aging neuroscience · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

María D Navarro-HortalBiomedical Research Center, Department of Physiology, Institute of Nutrition and Food Technology "José Mataix Verdú", University of Granada, Avda del Conocimiento s/n., 18100 Granada, Spain.ORCID 0000-0002-6225-8379
Jose M Romero-MárquezBiomedical Research Center, Department of Physiology, Institute of Nutrition and Food Technology "José Mataix Verdú", University of Granada, Avda del Conocimiento s/n., 18100 Granada, Spain.ORCID 0000-0001-7033-969X
Safa OstaBiomedical Research Center, Department of Physiology, Institute of Nutrition and Food Technology "José Mataix Verdú", University of Granada, Avda del Conocimiento s/n., 18100 Granada, Spain.
Victoria Jiménez-TrigoBiomedical Research Center, Department of Physiology, Institute of Nutrition and Food Technology "José Mataix Verdú", University of Granada, Avda del Conocimiento s/n., 18100 Granada, Spain.ORCID 0000-0001-6564-1368
Pedro Muñoz-OlleroBiomedical Research Center, Department of Physiology, Institute of Nutrition and Food Technology "José Mataix Verdú", University of Granada, Avda del Conocimiento s/n., 18100 Granada, Spain.
Alfonso Varela-LópezBiomedical Research Center, Department of Physiology, Institute of Nutrition and Food Technology "José Mataix Verdú", University of Granada, Avda del Conocimiento s/n., 18100 Granada, Spain.ORCID 0000-0002-0504-5086
Universidad de Granada · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) is an age-dependent, progressive disorder affecting millions of people. Currently, the therapeutics for AD only treat the symptoms. Although they have been used to discover new products of interest for this disease, mammalian models used to investigate the molecular determinants of this disease are often prohibitively expensive, time-consuming and very complex. On the other hand, cell cultures lack the organism complexity involved in AD. Given the highly conserved neurological pathways between mammals and invertebrates,

Indexed as

beta-amyloidfoodneurodegenerative diseasenutraceuticaltau protein

Identifiers

PMID35645249
PMCPMC9149938
OpenAlexW4280555238

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.